Albert David India

Kolkata, India Founded: 1938 • Age: 88 yrs Listed
Pharmaceutical formulations, infusions, and syringes are manufactured.
Request Access
Report Incorrect Data
Page last updated

About Albert David India

Albert David India is a publicly listed company based in Kolkata (India) founded in 1938. Pharmaceutical formulations, infusions, and syringes are manufactured. The company has 1,800 employees. Its Indian entity Albert David Ltd reported revenue of ₹341 Cr. Its focus areas include Diversified Pharmaceuticals and Drugs.

Company details

Albert David India was established in 1938 and is headquartered in Kolkata, India. Operations focus on the production of pharmaceutical formulations, infusion solutions, herbal dosage forms, bulk drugs, and disposable syringes with needles. A portfolio of 30 formulation products is maintained. Exports of these items are directed to multiple countries, supporting the healthcare sector through standard manufacturing practices.

  • Headquarters Kolkata, India
  • Employees 1,800
  • Stage Public
  • Sectors
    Healthcare
  • Website category Health · Biotechnology and Pharmaceuticals
  • Website albertdavidindia.com
  • Legal Name Albert David Ltd
Operational Areas
Healthcare → Pharmaceuticals & Distribution
Key Metrics
  • Market Cap
    ₹448 Cr

    ALBERTDAVD · NSE

  • Share Price
    ₹764.95

    -2.47% today

  • Revenue
    ₹334 Cr

    FY 2025-26 · -3.5% YoY

  • EBITDA
    ₹5.73 Cr

    Margin 1.7%

  • Net Profit
    −₹1.72 Cr

    FY 2025-26 · -110.2% YoY

  • P/E (TTM)
    20.2x

    P/B 1.2x

  • ROE
    -0.4%

    ROCE 0.8%

  • Debt / Equity
    0.05

    Interest cover -72.0x

  • Employee Count
    1,800

Board of directors of Albert David Ltd (Albert David India)

Albert David Ltd is the primary company behind Albert David India. The board of Albert David Ltd currently have 9 directors; the longest-serving is Arun Kumar Kothari, appointed in 1988. 22 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Arun Kumar Kothari
DIN 00051900
Whole-time director20 Jun 198838 yrs 4 moAlbert David Ltd
Prabhawati Devi Kothari
DIN 00051860
Director31 Mar 201412 yrs 6 moAlbert David Ltd
Monjori Mitra
DIN 02761691
Director24 Aug 20206 yrs 1 moAlbert David Ltd
Anand Vardhan Kothari
DIN 02572346
Director11 May 20224 yrs 5 moAlbert David Ltd
Shourya Sengupta
DIN 09216561
Director10 Aug 20233 yrs 2 moAlbert David Ltd
Anurag Singhi
DIN 01807541
Director01 Apr 20242 yrs 6 moAlbert David Ltd
Naresh Pachisia
DIN 00233768
Director14 Nov 20241 yr 11 moAlbert David Ltd
Rajiv Anant Desai
DIN 11193975
Director02 Aug 20251 yr 2 moAlbert David Ltd
Amit Mahla
DIN 11767012
Additional Director19 Jun 20264 moAlbert David Ltd

People of Albert David India

20 people are tracked at Albert David India (5 in leadership, 8 in board & advisors, 7 in team); the tracked headcount is 1,800.

NameRoleGroup
Umesh Kunte
Managing Director & CEOLeadership
A. B. Chakrabartty
Company Secretary & Compliance Officer cum Legal HeadLeadership
Ranadeep Bhattacharya
Chief Financial OfficerLeadership
Adijyoti Chattopadhyay
Corporate Head, HRLeadership
Chandra Bhushan Thakur
Head Operations (ghaziabad Unit)Leadership
A. K. Kothari
ChairmanBoard & advisors
Subhasri Bandyopadhyay
Senior Medical AdvisorBoard & advisors
Hemal Kampani
Board MemberBoard & advisors
Prabhawati Devi Kothari
Board MemberBoard & advisors
Shirish G. Belapure
Board MemberBoard & advisors
Arindam Sarkar
Board MemberBoard & advisors
Rajiv Singhi
Board MemberBoard & advisors
Monjori Mitra
Board MemberBoard & advisors
Indrajit Dhar
AVP, Accounts & TaxationTeam
Lalit Lohia
Company Secretary & Compliance OfficerTeam
Satish Gupta
Executive - HRTeam
Parthajeet Dutta Banik
Compliance & PayrollTeam
Sanjay Dudhoria
Deputy Manager Quality ControlTeam
Harjeet Singh
Training ManagerTeam
Ambika Roy
Human Resources InternTeam
Premium access

Complete people profiles for Albert David India

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

IPO & Listings of Albert David India

Albert David India is a publicly listed company on the NSE with ticker symbol ALBERTDAVD in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date14 Jun 2016
  • Listed onNSE: ALBERTDAVD
  • Listed entityAlbert David Ltd
  • Exchange sectorHealth technology
  • ISININE155C01010
  • Share price₹805.80 (-0.7% on the day) · 2026-10-14
  • Market capitalisation₹460 Cr
  • Price to earnings20.4
  • EPS (diluted, trailing year)₹39.54
  • Dividend yield0.62%
  • Volume (last session)357

Financials of Albert David India

Exchange-reported figures of Albert David Ltd, the listed company behind Albert David India (NSE: ALBERTDAVD).

Financial Highlights

FY 2025-26 · Standalone
Revenue
₹334 Cr
-3.5% YoY
EBITDA
₹5.73 Cr
+80.8% YoY
Profit After Tax
−₹1.72 Cr
-110.2% YoY
Net Worth
₹392 Cr
-0.2% YoY
Total Assets
₹428 Cr
+3.9% YoY
Total Debt
₹29.58 Cr
+140.1% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue334346362342314247321
Revenue growth-3.5%-4.6%+6.1%+9.0%+26.7%-22.9%-
EBITDA5.733.1746.9844.4640.9319.2830.52
EBITDA margin+1.7%+0.9%+13.0%+13.0%+13.1%+7.8%+9.5%
Profit before tax0.5225.2397.2750.7347.2927.4528.98
Net profit(1.72)16.8675.4036.1632.8821.4018.97
Net profit margin-0.5%+4.9%+20.8%+10.6%+10.5%+8.7%+5.9%
EPS (₹)(2.62)30.14132.1563.3861.7838.8033.59
Balance sheet
Total assets428412398329298261240
Net worth392392383312279244223
Total debt29.5812.323.325.325.671.622.04
Cash & bank32.771.6931.1625.2218.5635.376.75
Net working capital63.1518.6321.0143.22(7.09)29.7922.91
Cash flow
Cash from operations(7.66)(28.44)45.5010.5240.3636.6130.25
Cash from investing(4.38)23.30(33.24)(4.98)(39.62)(36.68)(19.92)
Cash from financing11.920.11(8.27)(6.36)(4.88)(1.71)(10.33)
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue10185.8689.9387.2470.5774.8983.0898.44
Revenue growth (YoY)+43.6%+14.7%+8.3%-11.4%-21.0%---
Other income27.96(24.84)12.40(2.14)22.04(5.11)(9.01)20.64
Total expenses90.7083.1179.1084.7081.2279.6482.4192.21
EBITDA10.642.7510.832.54(10.65)(4.75)0.676.23
EBITDA margin+10.5%+3.2%+12.0%+2.9%-15.1%-6.3%+0.8%+6.3%
Depreciation2.292.722.422.232.391.821.701.67
Interest0.520.430.900.750.550.130.130.06
Profit before tax35.79(25.24)19.91(2.58)8.45(11.81)(10.17)25.14
Tax3.80(3.80)4.600.720.50(1.48)(0.78)7.06

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 23 Oct 2026
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue10185.8689.9387.2470.5774.8983.0898.44
Revenue growth (YoY)+43.6%+14.7%+8.3%-11.4%-21.0%---
Other income27.96(24.84)12.40(2.14)22.04(5.11)(9.01)20.64
Total expenses90.7083.1179.1084.7081.2279.6482.4192.21
EBITDA10.642.7510.832.54(10.65)(4.75)0.676.23
EBITDA margin+10.5%+3.2%+12.0%+2.9%-15.1%-6.3%+0.8%+6.3%
Depreciation2.292.722.422.232.391.821.701.67
Interest0.520.430.900.750.550.130.130.06
Profit before tax35.79(25.24)19.91(2.58)8.45(11.81)(10.17)25.14
Tax3.80(3.80)4.600.720.50(1.48)(0.78)7.06
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue334346362342314247321
Revenue growth-3.5%-4.6%+6.1%+9.0%+26.7%-22.9%-
Other income7.4529.5857.5515.4015.8417.187.11
Total expenses328343315297273228290
Employee cost10210988.4381.0785.3882.7090.34
EBITDA5.733.1746.9844.4640.9319.2830.52
EBITDA margin+1.7%+0.9%+13.0%+13.0%+13.1%+7.8%+9.5%
Depreciation9.766.976.838.558.818.237.67
Interest2.900.550.430.580.670.780.98
Profit before tax0.5225.2397.2750.7347.2927.4528.98
Tax2.018.0221.8714.5612.045.309.79
Net profit(1.72)16.8675.4036.1632.8821.4018.97
Net profit margin-0.5%+4.9%+20.8%+10.6%+10.5%+8.7%+5.9%
EPS (₹)(2.62)30.14132.1563.3861.7838.8033.59
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital5.715.715.715.715.715.715.71
Reserves & surplus386387377306274239217
Shareholders' funds (net worth)392392383312279244223
Secured loans28.4810.052.103.973.770.431.44
Unsecured loans1.102.271.221.351.901.190.60
Total debt29.5812.323.325.325.671.622.04
Total liabilities428412398329298261240
Assets
Gross block262253233224224212212
Net block99.6598.7883.3980.0387.6883.9691.00
Capital work in progress20.771.926.742.720.810.751.52
Investments243260273193183138122
Inventories58.2763.9043.6150.6839.1835.7542.72
Sundry debtors33.9227.3729.3330.3325.0719.4930.13
Cash & bank balances32.771.6931.1625.2218.5635.376.75
Loans & advances24.3918.8613.2331.2314.5018.5423.69
Total current assets14911211713797.31109103
Total current liabilities86.2093.1996.3294.2410479.3680.38
Net working capital63.1518.6321.0143.22(7.09)29.7922.91
Total assets428412398329298261240
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash0.425.441.452.282.646.426.41
Net cash from operating activities(7.66)(28.44)45.5010.5240.3636.6130.25
Net cash from investing activities(4.38)23.30(33.24)(4.98)(39.62)(36.68)(19.92)
Net cash from financing activities11.920.11(8.27)(6.36)(4.88)(1.71)(10.33)
Net change in cash(0.12)(5.02)3.99(0.83)(4.13)(1.77)0.00
Closing cash32.771.6931.1625.2218.5635.376.75
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth-3.5%-4.6%+6.1%+9.0%+26.7%-22.9%-
EBITDA growth+80.8%-93.3%+5.7%+8.6%+112.3%-36.8%-
PBT growth-97.9%-74.1%+91.7%+7.3%+72.3%-5.3%-23.3%
Net income growth-110.2%-77.6%+108.5%+10.0%+53.6%+12.8%-
Revenue CAGR (3Y)-0.8%+3.3%+13.6%+2.1%-0.4%-4.9%+2.8%
EBITDA CAGR (3Y)-49.5%-57.4%+34.6%+13.4%+11.0%+1.9%+4.3%
Profitability & leverage
Net income margin-0.5%+5.0%+20.8%+10.6%+11.2%+9.0%+6.0%
Return on capital employed+0.8%+6.4%+26.9%+16.4%+17.2%+11.3%+12.9%
Return on net worth-0.4%+4.4%+21.7%+12.2%+13.5%+9.5%+8.9%
Debt / equity0.050.020.010.020.010.010.01
Long-term debt / equity0.000.000.000.000.000.000.00
Interest cover-71.96-14.471.071.622.097.064.29
Efficiency & per share
Fixed asset turnover1.301.421.591.531.441.171.59
Inventory turnover5.466.437.697.608.376.317.39
Debtors turnover10.8912.2012.1512.3514.079.9712.36
EPS (₹)(2.62)30.14132.1563.3861.7838.8033.59
Dividend per share (₹)5.005.0011.509.009.006.007.00
Book value per share (₹)686.04687.70671.05545.93489.68428.20390.38

Web traffic of Albert David India

The website of Albert David India (albertdavidindia.com) receives about 3.2K visits a month and ranks #6,337,167 among all websites worldwide, #6,541 in Biotechnology and Pharmaceuticals.

  • Monthly visits
    3.2K

    ▲ 22.2% vs previous month

  • Unique visitors
    1.1K

    per month

  • Global rank
    #6,337,167

    among all websites

  • Category rank
    #6,541

    Health · Biotechnology and Pharmaceuticals

Similar websites

Websites whose visitors overlap most with Albert David India. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
Unichem Labs
unichemlabs.com
100%
4.6K#3,871,645View details
intralifeindia.com
intralifeindia.com
62%
#1,019,069–
Boroline
boroline.com
61%
51.5K#616,168View details
hamdard.in
hamdard.in
52%
#507,242–
Sharda Boiron Laboratories
sblglobal.com
50%
174.1K#218,702View details
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Albert David India

Shivalik Bimetal Controls Ltd leads gainers in 'B' group | Capital Market News - Business Standard
Business Standard • 2 months ago
39 loss-making firms paid dividends in FY26, promoters walked away with crores
Moneycontrol • 4 months ago
Albert David Appoints Amit Mahla As CEO Effective May 12
Reuters • 5 months ago
Albert David Says Umesh Manohar Kunte Resigns As MD, CEO
Reuters • 10 months ago
Albert David Says Umesh Manohar Kunte Resigns As Managing Director And CEO
Reuters • 10 months ago
Albert David Approved Investment Upto 6.1 Million Rupees In Shares Of Sunsure Solarpark Five
Reuters • 3 years ago
India's Albert David March-Quarter Profit Falls
Reuters • 3 years ago
Zydus Health acquires gastro drug 'Actibile' from Albert David
Economictimes • 3 years ago
India's Albert David Dec-Quarter Profit Rises
Reuters • 3 years ago
Albert David names Umesh Kunte as CEO
Peoplematters • 3 years ago
Premium access

Complete news archive for Albert David India

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Albert David India

Albert David India was founded in 1938.

Albert David India is headquartered in Kolkata, India. It is registered at Kolkata, West Bengal, India.

Albert David India has 1,800 employees.

The primary company behind Albert David India, Albert David Ltd, reported revenue of ₹341 Cr for FY 2026, down 4% year on year.

Albert David India was established in 1938 and is headquartered in Kolkata, India. Operations focus on the production of pharmaceutical formulations, infusion solutions, herbal dosage forms, bulk drugs, and disposable syringes with needles. A portfolio of 30 formulation products is maintained. Exports of these items are directed to multiple countries, supporting the healthcare sector through standard manufacturing practices.

Yes, Albert David India is publicly traded on NSE under the ticker symbol ALBERTDAVD.

Albert David India operates through Albert David Ltd.

The legal entities of Albert David India currently have 11 directors, including Arun Kumar Kothari, Prabhawati Devi Kothari, Monjori Mitra and others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available